Tomas Deierborg Selected Research

Tomas Deierborg Research Topics

Disease

15	Stroke (Strokes) 01/2022 - 03/2008
10	Infarction (Infarctions) 01/2022 - 03/2008
8	Inflammation (Inflammations) 01/2021 - 11/2014
7	Brain Ischemia (Cerebral Ischemia) 01/2016 - 02/2009
5	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 04/2011
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 08/2008
4	Ischemia 12/2016 - 06/2008
3	Neuroinflammatory Diseases 01/2022 - 01/2016
3	Ischemic Stroke 02/2017 - 01/2016
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 04/2011
2	Synucleinopathies 01/2021 - 11/2014
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 09/2020 - 10/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 06/2008
2	Necrosis 02/2017 - 01/2016
1	Brain Diseases (Brain Disorder) 01/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 09/2020
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 09/2020
1	Out-of-Hospital Cardiac Arrest 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Infections 01/2020
1	COVID-19 01/2020
1	Epilepsy (Aura) 12/2019
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Muscular Dystrophies (Muscular Dystrophy) 10/2017
1	Edema (Dropsy) 01/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017
1	Craniocerebral Trauma (Head Injury) 01/2017
1	Starvation 03/2016
1	Neuromyelitis Optica (Devic's Disease) 01/2016
1	Disease Progression 01/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016
1	Multiple Sclerosis 11/2015
1	Anhedonia 09/2015
1	Multiple System Atrophy 08/2015
1	Retinal Degeneration 05/2015
1	Gliosis 05/2015

Drug/Important Bio-Agent (IBA)

10	Galectin 3 (LGALS3)IBA 01/2022 - 04/2011
8	CytokinesIBA 01/2022 - 11/2015
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 02/2009
3	Amyloid beta-PeptidesIBA 10/2021 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 02/2017 - 01/2016
2	LipopolysaccharidesIBA 01/2021 - 03/2015
2	alpha-SynucleinIBA 01/2021 - 08/2015
2	GTP-Binding Proteins (G-Protein)IBA 01/2018 - 09/2014
2	Interleukin-2 (IL2)IBA 02/2017 - 01/2016
2	Neuroprotective AgentsIBA 05/2016 - 02/2009
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2008
2	CaspasesIBA 01/2016 - 04/2011
2	Retinaldehyde (Retinal)IBA 01/2016 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 01/2016
2	Macrophage Migration-Inhibitory FactorsIBA 06/2011 - 04/2011
1	PrionsIBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 03/2021
1	MHC class II transactivator proteinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Synapsins (Synapsin I)IBA 12/2019
1	Peptides (Polypeptides)IBA 01/2019
1	LigandsIBA 01/2019
1	pimonidazoleIBA 01/2018
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2018
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2018
1	Laminin (Merosin)IBA 10/2017
1	OsteopontinIBA 10/2017
1	Interleukin-10 (Interleukin 10)IBA 02/2017
1	Interleukin-8 (Interleukin 8)IBA 02/2017
1	InterleukinsIBA 02/2017
1	Neutralizing AntibodiesIBA 01/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2017
1	AlarminsIBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	AcidsIBA 01/2017
1	FumaratesIBA 01/2017
1	CorticosteroneIBA 12/2016
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2016
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 03/2016
1	Protein Kinase InhibitorsIBA 03/2016
1	StaurosporineIBA 03/2016
1	Caspase 8 (Caspase-8)IBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	ChemokinesIBA 01/2016
1	AutoantibodiesIBA 01/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2016
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	InterferonsIBA 11/2015
1	Sucrose (Saccharose)IBA 09/2015
1	A-factor (Streptomyces)IBA 05/2015
1	XENP 1595IBA 12/2014
1	Etanercept (Enbrel)FDA Link 12/2014
1	Polymethyl Methacrylate (Sol)IBA 12/2014

Therapy/Procedure

6	Therapeutics 10/2017 - 08/2008
1	Injections 01/2021
1	Induced Hypothermia 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2016